Article
Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease.
Archives of pathology & laboratory medicine - 1 Sept 1990
de Mascarel I, Trojani M, Eghbali H, Coindre J M, Bonichon F
Abstract excerpt
The purpose of this report is to assess whether phenotyping by three monoclonal antibodies routinely used in paraffin sections (Ber-H2-Leu-M1-EMA) and shown to be the most useful for diagnosis may be a predictive factor for recurrences. Among 563 patients diagnosed as having Hodgkin's disease (24% of whom had recurrence), we selected 153 patients with and without recurrence, with matching clinical stage. For all...
Topics
- Antigens, CD
- Antigens, Differentiation
- Antigens, Differentiation, Myelomonocytic
- Antigens, Neoplasm
- Biomarkers, Tumor
- Hodgkin Disease
- Humans
- Immunohistochemistry
- Ki-1 Antigen
- Lewis X Antigen
- Membrane Glycoproteins